Top member reports
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#FY26 projection
stale
Bioxyne just confidently announced a >100% growth projection for FY26 in both revenue and EBITDA.
Seems pretty cheap if that's the case? NPAT was $5m and market cap is $120m....
